Immunoexpression of angiogenesis and proliferation markers in patients treated with cyclosporin A

Minerva Stomatol. 2014 Mar;63(3):59-67.

Abstract

Aim: In the present immunohistochemical study, the expression of vascular endothelial growth factor, nitric oxide synthase 1 and 3, and Ki-67 in the gingival tissues of renal transplant patients treated with cyclosporin A was assessed. Gingival overgrowth (GO) frequently occurs in transplant patients receiving immunosuppressive drugs such as cyclosporine and this gingival inflammation might play an important role in the pathogenesis of drug-induced GO.

Methods: Twenty-eight human gingival biopsies were taken from healthy patients with chronic periodontitis (N.=14 control group), and from renal transplant recipients treated with cyclosporin A (N.=14 test group). The retrieved specimens were immunohistochemically processed and stained for vascular endothelial growth factor, nitric oxide synthase 1 and 3, and Ki-67.

Results: The levels of vascular endothelial growth factor, nitric oxide synthase 1 and 3, and Ki-67 were found to be significantly different among groups (P>0.001), with patients treated with cyclosporin A showing higher levels of all the analyzed markers compared to control group.

Conclusion: In summary, the data from this pilot study suggests that the investigated factors have a role in the inflammation processes associated to immunosuppressive therapy. However, further studies with a larger sample population need to be conducted for an exhaustive knowledge of the mechanisms leading to GO.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Biomarkers
  • Biopsy
  • Cyclosporine / adverse effects*
  • Cyclosporine / pharmacology
  • Female
  • Gingiva / blood supply
  • Gingiva / pathology
  • Gingival Hypertrophy / chemically induced*
  • Gingival Hypertrophy / metabolism
  • Gingival Hypertrophy / pathology
  • Humans
  • Immunoenzyme Techniques
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / pharmacology
  • Inflammation
  • Ki-67 Antigen / analysis*
  • Kidney Transplantation*
  • Male
  • Middle Aged
  • Neovascularization, Physiologic
  • Nitric Oxide Synthase Type II / analysis*
  • Nitric Oxide Synthase Type III / analysis*
  • Periodontitis / metabolism
  • Postoperative Complications / chemically induced*
  • Postoperative Complications / metabolism
  • Postoperative Complications / pathology
  • Vascular Endothelial Growth Factor A / analysis*
  • Young Adult

Substances

  • Biomarkers
  • Immunosuppressive Agents
  • Ki-67 Antigen
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Cyclosporine
  • NOS2 protein, human
  • NOS3 protein, human
  • Nitric Oxide Synthase Type II
  • Nitric Oxide Synthase Type III